Education
About Us
Working with TipRanks
Follow Us
Linical Co., Ltd. (JP:2183)
:2183
2183 Stock Chart & Stats
¥342.00
-¥1.00(-0.28%)
At close: 4:00 PM EST
¥342.00
-¥1.00(-0.28%)
Day’s Range― - ―
52-Week Range¥258.00 - ¥387.00
Previous CloseN/A
Volume36.50K
Average Volume (3M)14.99K
Market Cap
¥7.72B
Enterprise Value¥4.23B
Total Cash (Recent Filing)¥5.53B
Total Debt (Recent Filing)¥2.22B
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Nov 14, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 28, 2025Dividend Yield4.68%
Share Statistics
EPS (TTM)-7.83
Shares Outstanding24,740,000
10 Day Avg. Volume18,600
30 Day Avg. Volume14,993
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)1.00
Price to Sales (P/S)0.69
P/FCF Ratio12.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥357.00Price Target Upside4.39% Upside
Rating ConsensusHold
Number of Analyst Covering0
Linical Co., Ltd. News
2183 FAQ
What was Linical Co., Ltd.’s price range in the past 12 months?
Linical Co., Ltd. lowest stock price was ¥258.00 and its highest was ¥387.00 in the past 12 months.
What is Linical Co., Ltd.’s market cap?
Linical Co., Ltd.’s market cap is ¥7.72B.
When is Linical Co., Ltd.’s upcoming earnings report date?
Linical Co., Ltd.’s upcoming earnings report date is Nov 14, 2025 which is in 25 days.
How were Linical Co., Ltd.’s earnings last quarter?
Linical Co., Ltd. released its earnings results on Aug 14, 2025. The company reported -¥7.83 earnings per share for the quarter, missing the consensus estimate of N/A by -¥7.83.
Is Linical Co., Ltd. overvalued?
According to Wall Street analysts Linical Co., Ltd.’s price is currently Undervalued.
Does Linical Co., Ltd. pay dividends?
Linical Co., Ltd. pays a Annually dividend of ¥16 which represents an annual dividend yield of 4.68%. See more information on Linical Co., Ltd. dividends here
What is Linical Co., Ltd.’s EPS estimate?
Linical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Linical Co., Ltd. have?
Linical Co., Ltd. has 24,740,000 shares outstanding.
What happened to Linical Co., Ltd.’s price movement after its last earnings report?
Linical Co., Ltd. reported an EPS of -¥7.83 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.213%.
Which hedge fund is a major shareholder of Linical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:2183
Company Description
Linical Co., Ltd.
Linical Co., Ltd. is a Contract Research Organization (CRO) that operates primarily in the pharmaceutical and biotechnology sectors. The company provides a comprehensive portfolio of services, including clinical trial management, data management, pharmaceutical development, and regulatory consulting. Linical is dedicated to supporting the development and commercialization of pharmaceutical products globally, with a strong presence in Europe, Asia, and North America.
Technical Analysis
OncoTherapy Science
―
Cytori Cell Research Institute, Inc.
―
Kidswell Bio Corporation
―
TMS Co., Ltd.
―
Noile-Immune Biotech Inc.
―
Options Prices
Currently, No data available
---